Saturday Regional Coding Seminar (2018)

July 21, 2018

CPT and ICD-10-CM codes have been updated and physicians and the staff of the urology practices do not have the knowledge to accurately apply correct codes for diseases, signs, and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or disease.

Physician and staff in urology practices need training to understand and apply the CPT and ICD-10-CM codes to ensure procedures are properly coded for accurate billing. (Current Procedural Terminology(CPT)) - the most widely accepted medical nomenclature used to report medical procedures and services under public and private health insurance programs.

Target Audience

This course is designed for:

  • Urologists
  • Nurses
  • Medical Technicians/Assistants
  • Practice Managers

Learning Objectives

Saturday General Session:
1. List the coding changes effecting urology in 2018
2. List the changes to Medicare for 2018
3. Describe the proper use of tools for prior authorization
4. List the changes to MACRA, MIPS & APM for 2018
5. Determine proper steps to take to negotiate contracts
6. Apply the appropriate level of evaluation and management services
7. Describe proper modifiers to use in everyday practice
8. Discuss surgical procedures done by providers and how to properly code each.

Course summary
Available credit: 
  • 7.00 AMA PRA Category 1 Credit™
  • 7.00 Non-Physician Participation
Course opens: 
07/20/2018
Course expires: 
07/21/2021
Event starts: 
07/21/2018 - 12:00am EDT
Event ends: 
07/21/2018 - 11:59pm EDT
Rating: 
0

American Urological Association

2018 Regional Coding Seminar Agenda

Faculty: Edna R. Maldonado, CPC, ICD-10-CM Trainer

Stephanie Stinchcomb, CPC, CCS-P, ICD-10-CM Trainer

Guest Speakers: Jonathan Rubenstein, MD

 

 

AGENDA

08:00-8:30 am  

Registration—Continental Breakfast

08:30-9:00 am  

Urology Coding Updates for 2018

(New, Revised & Deleted codes for 2018)

09:00-10:00 am

What you need to know about Medicare Updates! 

10:00-10:30 am

What your Practice needs to know about Prior Authorization! 

10:30-10:45 am

Break    

10:45-12:15 pm

Evaluation & Management Documentation Strategies

12:15-1:00 pm  

Lunch

1:00-2:00 pm    

Negotiating Payer Contracts 

2:00-3:00 pm    

Stay Up to Date with MACRA, MIPS & APM 

3:00-3:15 pm    

Break

3:15-4:15 pm    

How well do you know your Modifiers? 

 4:15-4:45 pm    

Panel Q&A Coding Scenarios

Las Vegas, NV
United States

Faculty Disclosures

Name

Company

Role

Financial

Joel Dunay – Practice Management Senior Manager

Nothing to disclose

  

Edna Maldonado - Coding Coordinator

Nothing to disclose

  

Stephanie Stinchcomb – Reimbursement & Regulations Director

Nothing to disclose

  

Latarsha Fisher – Coding Coordinator

Nothing to disclose

  

Jonathan Rubenstein, MD

Nothing to disclose

  

Jay Motola, MD

Spectrum Pharmaceutical

Scientific Study or Trial

 
 

Allied Urological/Metropolitan Lithotripsy

Investment Interest

 
 

Health Central

Health Publishing

 
 

Ferring Pharmaceutical

Scientific Study or Trial

 
 

Pfizer

Meeting Participant or Lecturer

 
 

Healthronic

Consultant of Adviser, Meeting Participant or Lecturer

 

Max Reiboldt

Coker Group

President/CEO

 

Victor Nitti, MD - Chair, AUA Office of Education

Serenity Pharmaceuticals

Investment Interest

Yes

Michael Abern, MD – Chair, Content Review Work Group

Nothing to Disclose

  

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: The American Urological Association designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

AUA PARTICIPANT INFORMATION & POLICIES

Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Consent to Use of Photographic Images: Attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the attendee's image or voice in photographs and electronic reproductions of such meetings and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.

Available Credit

  • 7.00 AMA PRA Category 1 Credit™
  • 7.00 Non-Physician Participation
Please login or register to take this course.